A multi-centre, randomized, open-label, study to compare conversion from calcineurin inhibitors to rapamune [sirolimus] versus standard therapy in established renal allograft recipients on maintenance therapy with mild to moderate renal insufficiency

Trial Profile

A multi-centre, randomized, open-label, study to compare conversion from calcineurin inhibitors to rapamune [sirolimus] versus standard therapy in established renal allograft recipients on maintenance therapy with mild to moderate renal insufficiency

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Mar 2011

At a glance

  • Drugs Sirolimus (Primary) ; Ciclosporin; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 03 Jun 2009 Results were published at the American Transplant Congress -- 9th Joint Congress of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST).
    • 31 May 2007 Status changed from in progress to completed.
    • 10 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top